PET is significantly more proficient than SPECT in detecting severe obstructive coronary artery disease (CAD), enabling more appropriate use of revascularization treatment, according to a study presented at the American College of Cardiology (ACC) meeting in Orlando, FL. 


Fill Text 


 ... Read More


By performing myocardial perfusion imaging (MPI) with cardiac FDG-PET before revascularization, clinicians can better assess the benefits of that procedure and predict near-term outcomes for patients with coronary artery disease and left ventricular dysfunction, according to a study presented on Sunday at RSNA 2018.... Read More


Heart disease is a danger like no other, meaning proper diagnosis is of paramount importance. PET scans have been, and continue to be, the best way to get such a diagnosis.


Full Text


Why PET Will Beat SPECT in the Next Decade

While there is buzz around new PET agents in neurology for detecting beta amyloid plaques associated with Alzheimer’s disease, it is cardiology that presents some of the most exciting opportunities for PET. New cardiac PET agents promise robust, reproducible and dependable results in everyday cardiology practices.... Read More


CEO issues letter to shareholders

Dear Fellow Positron Shareholders,

This letter will serve as a means to update and inform you about the activities and opportunities that exist as a shareholder in Positron Corporation. Positron is a leader in molecular imaging, focused on the field of nuclear cardiology. Positron provides innovative technologies... Read More